DPIIT recognised startup Government of India
Startup India
Trumedis Pharmaceuticals Private Limited - electrnoics in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹42.85 Lakh
▼ 25.51% YoY
Net profit · FY 2025
₹1.68 Lakh
Net margin 3.9%
EBITDA · FY 2025
₹2.45 Lakh
EBITDA margin 5.7%
Authorised capital
₹9.75 Lakh
Registered with MCA
Paid-up capital
₹3.9 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Trumedis Pharmaceuticals Private Limited
Data last updated:
Trumedis Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India, recognised as a startup by DPIIT. It operates in the repair services segment of the electronics sector. It was incorporated on 27 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52609DL2019PTC351943. Its GSTIN is 10AAHCT4012B1Z9 (Bihar).
The company has an authorised share capital of ₹9.75 Lakh and a paid-up capital of ₹3.9 Lakh. It is led by directors Neelesh Kumar and Bhagirath Prasad Sinha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E 44/3 Ground Floor, Okhla Industrial Area Phase – 2, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹42.85 Lakh. For the same year it recorded a net profit of ₹1.68 Lakh (net margin 3.9%) and EBITDA of ₹2.45 Lakh (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years and 28% over five years.
The company is associated with 1 brand: Trumedispharma.
For more details, the company can be reached via its website trumedispharma.com.
Company details
CIN U52609DL2019PTC351943
Registration Number 351943
Incorporation Date 27 June 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Trumedis Pharmaceuticals
Contact details
Trumedis Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is trumedispharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressE 44/3 Ground Floor, Okhla Industrial Area Phase – 2, New Delhi, Delhi, India – 110020
- IndustryElectrnoics, Repair Services
To see the full contact details of Trumedis Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Trumedis Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Trumedis Pharmaceuticals operates one associated brand: Trumedispharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides high-quality allopathic medicines, dietary supplements, and homeopathy for masses. | trumedispharma.com |
Business activity
The main business activity of Trumedis Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Trumedis Pharmaceuticals Private Limited, buy the company report.
Financials of Trumedis Pharmaceuticals Private Limited
FY 2025 filings availableTrumedis Pharmaceuticals Private Limited reported revenue of ₹42.85 Lakh for FY 2025.
Revenue · FY 2025
₹42.85 Lakh
Net profit · FY 2025
₹1.68 Lakh margin 3.9%
EBITDA · FY 2025
₹2.45 Lakh margin 5.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 40%
5 years · compounded
▲ 28%
EBITDA CAGR growth
1 year
▼ 11%
3 years · compounded
▲ 220%
5 years · compounded
▲ 38%
Revenue has grown at a compounded annual rate (CAGR) of 28% over five years. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.45 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.68 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | ||||
| Net Profit Margin | 3.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Trumedis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Trumedis Pharmaceuticals Private Limited
Trumedis Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neelesh Kumar Also directs: Sentinel Education LLP, Noxis Food Labs Private Limited | Director | 27 Jun 2019 | 7 Years 3 Months | Current |
| Bhagirath Prasad Sinha | Director | 27 Jun 2019 | 7 Years 3 Months | Current |
Peer comparison
Trumedis Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SMV Pharmaceuticals Private Limited | ₹42.95 Lakh (FY 2025) | 2.0% | Chandigarh, India | |||
| Arlics Pharmaceuticals Private Limited | ₹42.92 Lakh (FY 2025) | 1.0% | Mehsana, Gujarat, India | |||
| Torrey Pharmaceuticals Private Limited | ₹42.92 Lakh (FY 2024) | 116.0% | Nagpur, Maharashtra, India | |||
| Denexo Pharmaceuticals Private Limited | ₹42.9 Lakh (FY 2025) | 4.0% | Kharghar, Maharashtra, India | |||
| Trumedis Pharmaceuticals Private Limitedthis company | ₹42.85 Lakh (FY 2025) | ₹1.68 Lakh | 3.9% | New Delhi, Delhi, India | ||
| Wevet Pharmaceuticals Private Limited | ₹42.84 Lakh (FY 2024) | 69.0% | Allahabad, Uttar Pradesh, India |
To see the full peer comparison of Trumedis Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Trumedis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Trumedis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Trumedis Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCT4012B1Z9 | Bihar | Active | 27 Jan 2020 |
To see the full GST registrations and return filing status of Trumedis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Trumedis Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Bhagirath Prasad Sinha was appointed as Director on 27 Jun 2019.
AGM
Trumedis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Trumedis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Bhagirath Prasad Sinha was appointed as Director.
Appointed
Neelesh Kumar was appointed as Director.
Incorporation
27 Jun 2019
Trumedis Pharmaceuticals Private Limited was registered on 27 Jun 2019 with Roc Delhi & aged 7 years 3 months as per MCA records.
Frequently asked questions
Trumedis Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in repair services, within the electronics industry. It was incorporated on 27 June 2019 (7+ years old) and is registered under CIN U52609DL2019PTC351943.
Trumedis Pharmaceuticals has 2 current directors:
- Neelesh Kumar - Director
- Bhagirath Prasad Sinha - Director
The latest financial statements of Trumedis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Trumedis Pharmaceuticals is 10AAHCT4012B1Z9, registered in Bihar.
The CIN (Corporate Identification Number) of Trumedis Pharmaceuticals is U52609DL2019PTC351943. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Trumedis Pharmaceuticals was incorporated on 27 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Trumedis Pharmaceuticals by revenue are SMV Pharmaceuticals Private Limited, Arlics Pharmaceuticals Private Limited, Torrey Pharmaceuticals Private Limited, Denexo Pharmaceuticals Private Limited, Wevet Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Bhagirath Prasad Sinha was appointed as Director on 27 Jun 2019. Neelesh Kumar was appointed as Director on 27 Jun 2019.
Yes, Trumedis Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Trumedis Pharmaceuticals can be reached through the website trumedispharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Trumedis Pharmaceuticals is at E 443 Ground Floor, Okhla Industrial Area Phase – 2, New Delhi, Delhi, India – 110020.